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Background: Pisa syndrome (PS) is a lateral flexion of the trunk frequently associated
with Parkinson’s disease (PD). The pathophysiology of PS remains unclear, but the role
of cognitive deficits has been postulated.
Methods: We included 12 consecutive PD patients with PS (PS+) and 12 PD patients
without PS (PS–) matched for gender, age, level of education, PD duration, and PD stage.
As primary aim, we compared the neuropsychological scores of 16 tests evaluating
6 cognitive domains between PS+ and PS–. Additionally, we evaluated the presence
of misperception of the trunk position in PS+, defined as a mismatch between the
objective vs. subjective evaluation of the trunk bending angle>5◦, and analyzed whether
a correlation exists between the misperception of the trunk position and alterations in the
visual-spatial abilities.
Results: PS+ group showed significantly worse performances in the visual-spatial
abilities (p: 0.008), attentional domain (p: 0.001), and language domain (p: 0.023). No
differences were found in the other cognitive domains nor in the general cognitive
assessment. All PS+ patients showed a misperception of the trunk position, with
an average underestimation of the trunk bending angle of 11.7◦ ± 4.3. The degree
of misperception of the trunk position showed a trend toward a correlation with the
visual-spatial scores (p: 0.089).
Conclusions: The study reveals an association between PS and specific cognitive
alterations, suggesting a possible link between the abnormal posture of PD patients with
PS and their cognitive functions.
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INTRODUCTION
Pisa syndrome (PS) is a posture abnormality characterized by lateral flexion of the trunk appearing
or worsening while standing or walking and improving with passive mobilization and supine
positioning (1). PS has an estimated prevalence of 7.4–10.3% in Parkinson’s disease (PD), and
demonstrated a relevant impact on patients’ disability, being associated with low-back pain,
imbalance, and quality of life impairment (1, 2). The pathophysiology of PS is still unclear, and
different hypotheses have been postulated over time, which can be summarized in two main groups
(1): a central hypothesis, encompassing a hyperactivation of axial muscles related to an imbalance of
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basal ganglia network output or an altered sensory-
motor integration; and a peripheral hypothesis, related to
musculoskeletal pathology with myopathic alterations in
paraspinal muscles (2). Recent evidence, however, suggests
that cognitive processes are involved in the pathophysiological
mechanisms of PS (3). In particular, preliminary data showed
that verticality perception deficits and altered visual-spatial
functions might represent a typical feature of PD patients with
PS (3, 4).
In this pilot cross-sectional study, we sought to analyze
the differences in the cognitive profile of PD patients
with and without PS. As primary aim, we compared the
neuropsychological scores of 6 cognitive domains between PD
patients with PS and a control group of matched PD patients
without posture alterations. As secondary aims, we evaluated the
presence of misperception of the trunk position in PD patients
with PS, and analyzed whether a correlation exists between
the misperception of the trunk position and alterations in the
visual-spatial abilities.
MATERIALS AND METHODS
Study Population
In this pilot cross-sectional study we included all consecutive
consenting patients attending the Movement Disorder Center
of the Turin University Hospital between January 2018 and
June 2018 satisfying the following inclusion criteria: diagnosis
of idiopathic PD (5) and presence of PS, defined as minimum
10◦ lateral flexion of the trunk that could be reduced by
passive mobilization or supine positioning (PS+ group) (1).
We excluded patients with: (a) age >80 years, (b) orthopedic
issues complicating PS, encompassing vertebral fractures, severe
osteoporosis, spondylodiscitis, idiopathic scoliosis with vertebral
rotation, and history of major spine surgery, and (c) patients
treated with cholinesterase inhibitors, neuroleptics, tricyclic
antidepressants, and deep brain stimulation.
Controls (PS– group) were PD patients without PS or other
posture alterations matched in a case-control design for the
following clinical and demographic features: gender, age (±3
years), level of education, PD duration (±3 years) and stage
of PD, according to the Hoehn and Yahr (HY) score (6). The
same exclusion criteria applied for PS+ patients were used for
PS– patients.
Outcome Measures
All patients underwent an extensive clinical, neurological and
neuropsychological assessment performed in their best clinical
condition, defined as the time-frame in which the patient
experiences the best control of PD symptoms, according to the
judgment of the patient himself and the investigator.
Neuropsychological Assessment
Patients underwent a brief cognitive screening instrument, the
Montreal-Cognitive Assessment (MoCA) (7). Then they were
submitted to an extensive neuropsychological battery, assessing
six cognitive domains: visual-spatial, memory, reasoning,
attention, executive functions, and language.
Visuo-spatial abilities were assessed by Benton Judgment
of Line Orientation (BJLOT) (8), Constructional Apraxia Test
(CAT) (9) and Rey–Osterrieth Complex Figure Test (copy—
ROCFT) (10). The memory domain was assessed by Italian Bi-
syllabic Words Repetition Test (BWRT) (9), Digit Span (DST)
(11), and Corsi’s Block Tapping Test (CBT) (9) for verbal,
numerical and spatial short-term memory; and by Rey auditory
verbal learning (RAVLT) (12) and Rey–Osterrieth Complex
Figure Test (delayed recall—ROCFT) for learning (10). Non-
verbal reasoning was assessed by Raven Color Progressive
FIGURE 1 | Example of the objective measurement of lateral trunk flexion in a
patient with Pisa syndrome. The objective trunk position was calculated using
“ImageJ” software, an open source image processing program developed by
the National Institute of Health and validated for posture analysis (22). The
patient gave his written informed consent for the publication of the picture.
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Matrices Test (RCPMT) (13). The attentional domain was
assessed by Digit Cancellation Test (DCT) (9) and Trail Making
Test A (TMT A) (14). Executive functions were assessed by Trail
Making Test B (TMT B) (14), TMT B-A (14), Frontal Assessment
Battery (FAB) (15), andModified Card Sorting Test (MCST) (16).
The language was assessed by Phonemic Verbal Fluency (PVF)
(9) and Semantic Verbal Fluency (SVF) tasks (17).
Age and education appropriate normative data were used
to adjust the raw scores obtained by patients in each
neuropsychological test. To obtain comparable categorical data
the adjusted score of each test was rated as: 0, normal
performance; 1, limited performance; 2, moderate impairment;
3, severe impairment, according to the equivalent scores based
on the percentiles of population normative data (18–20). Then,
for each cognitive domain, we obtained a Cognitive Index (CI),
corresponding to the average value (0–3) of the related tests (18).
Misperception of the Trunk Position
The misperception of the trunk position was calculated as the
mismatch between the objective vs. subjective evaluation of the
trunk bending angle. In absence of validated criteria for the
clinically meaningful change in trunk alterations, we relied on
a cut-off of 5◦ as previously reported (21), and considered a
mismatch>5◦ as a misperception of the trunk position.
The objective trunk position was calculated using “ImageJ”
free software by capturing planar view photos of the patient
standing in front of a wall goniometer, drawing a line between the
7th spinous process and the midpoint of the superior posterior
iliac spine, and calculating the angle between this line and the
vertical passing through the midpoint of the superior posterior
iliac spine (Figure 1) (22).
The subjective trunk position was calculated by asking the
patient to estimate his lateral trunk flexion angle specifying
his/her own perceived trunk bending side and degrees while
maintaining the standing position with open eyes (23).
Finally, further evaluation of an altered perception of the
trunk position was obtained passively moving the patient with
closed eyes from his natural trunk position to the vertical line
(0◦), and asking him to estimate if he still feels his trunk bending
and, if so, on which side.
Demographic and Clinical Data
Other demographic and clinical data analyzed were: age, sex,
age at PD onset, age at PS onset, PS duration, side of trunk
deviation, MDS-UPDRS part III total score (6), HY score
(6), pharmacological therapy, and Levodopa Equivalent Daily
Dose (LEDD).
The following behavioral measures were also collected:
depression, evaluated bymeans of the Beck Depression Inventory
(BDI) (24); apathy, evaluated by means of the Apathy Scale (AS)
(25); and anxiety, evaluated by means of the State-Trait Anxiety
Inventory (STAI - X Form) (26).
Statistical Analysis
Demographic and clinical features were summarized as mean
± standard deviation or percentages, as appropriate. The non-
parametric Mann-Whitney test or the Fisher exact test was
used to compare PS+ vs. PS– group neuropsychological and
clinical data.
The correlation between the visual-spatial
domain score and the degree of misperception of
trunk position was performed by the Spearman
correlation test.
All p-values reported are two-tailed and a p < 0.05 was
considered statistically significant. Data were analyzed using the
Statistical Package for the Social Sciences (SPSS 22 for Mac,
Chicago, IL).
The local ethical committee approved the
study and all patients included gave their written
informed consent.
TABLE 1 | Patients’ demographic and clinical features.
Overall
sample
PS+ group PS– group p-value
Sex (male/female) 16/8 8/4 8/4 1.000
Age (years) 67.6 ± 9.9
(48–80)
67.8 ± 9.9
(49–80)
67.3 ± 10.3
(48–80)
0.839
Education (years) 10.5 ± 3.4
(5–15)
10.6 ± 3.5
(5–15)
10.3 ± 3.6
(5–14)
0.929
Disease duration
(years)
9.5 ± 4.7
(3–17)
10.4 ± 4.9
(3–17)
8.5 ± 4.4
(3–17)
0.354
Age at diagnosis
(years)
58.2 ± 10.2
(38–73)
57.5 ± 10.4
(38–73)
58.8 ± 10.4
(40–73)
0.840
Age at PS onset
(years)
63.2 ± 9.3
(47–77)
63.2 ± 9.3
(47–77)
n.a. n.a.
PS duration
(years)
3.2 ± 2.4
(0–7)
3.2 ± 2.4
(0–7)
n.a. n.a.
Side of trunk
deviation
(right/left)
7/5 7/5 n.a. n.a.
MDS-UPDRS III 39.3 ± 15.2
(13–67)
49.3 ± 10.4
(34–67)
29.3 ± 12.5
(13–51)
0.002
Hoehn & Yahr 2.5 ± 0.6
(2–4)
2.7 ± 0.5
(2–4)
2.2 ± 0.6
(2–4)
0.068
Phenotype
(Tremor/Akinetic-
rigid/Mixed)
0/18/6 0/9/3 0/9/3 0.104
LEDD (mg) 828.3 ± 316
(205–1400)
797.1 ± 303.4
(300–1350)
859.5 ± 341.5
(205–1400)
0.545
MMSE 27.9 ± 1.9
(23–30)
27.3 ± 2.1
(23–29)
28.5 ± 1.3
(26–30)
0.175
BDI II 11.7 ± 6.8
(0–24)
12 ± 7
(0–21)
11.5 ± 7
(5–24)
0.788
AS 14.4 ± 7.2
(3–28)
16.2 ± 7.5
(4–28)
12.9 ± 7
(3–26)
0.328
STAI X1 46 ± 11.7
(21–67)
47 ± 13.1
(21–60)
45.2 ± 11.4
(35–67)
0.563
STAI X2 42.3 ± 11.8
(22–60)
46 ± 12.6
(22–59)
39.4 ± 10.6
(26–60)
0.248
All data are reported as mean ± standard deviation (range), with the exception of sex
and phenotype. MDS-UPDRS, Movement Disorders Society–Unified Parkinson’s Disease
Rating Scale; n.a., not applicable; LEDD, Levodopa Equivalent Daily Dosage; MMSE, Mini
Mental State Examination; BDI II, Beck Depression Inventory II; AS, Apathy Scale; STAI X1,
State-Trait Anxiety Inventory X Form (state anxiety); STAI X2, State-Trait Anxiety Inventory
X Form (trait anxiety). Bold values mean statistically significant difference.
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FIGURE 2 | Comparison of the six cognitive domains scores between patients with Pisa syndrome and patients without posture alterations. PS+, patients with
Parkinson disease and with Pisa syndrome; PS–, patients with Parkinson disease and without Pisa syndrome; *statistically significant difference. Columns represent
the mean values of the Cognitive Index, and bars indicate the standard deviation.
RESULTS
A total of 24 PD patients were enrolled in the study according
to the inclusion/exclusion criteria: 12 patients for the PS+
group and 12 patients for the PS– group. The demographic
and clinical features of patients are summarized in Table 1.
No significant difference was found for age, education, PD
duration, PD phenotype, HY stage, and LEDD between the 2
groups (Table 1). The only difference in the demographic and
clinical features analyzed was in the MDS-UPDRS III score,
with PS+ patients showing a higher score (49.3 ± 10.4 vs.
29.3± 12.5; p: 0.002).
Neuropsychological Assessment
The global cognitive evaluation did not show a significant
difference between the two groups, with a MOCA score of 21.7
± 4.8 for PS+ vs. 23.5± 3.9 for PS– (p: 0.223).
PS+ group showed a significantly worse performance in
visual-spatial abilities (CI PS+ = 1.3 ± 1.1 vs. CI PS– = 0.3 ±
0.5; p: 0.008), attentional domain (CI PS+ = 1.5 ± 0.9 vs. CI
PS– = 0.25 ± 0.6; p: 0.001), and language (CI PS+ = 0.9 ±
0.9 vs. CI PS– = 0.2 ± 0.4; p: 0.023). No significant differences
were observed in the other cognitive domains evaluated
(Figure 2; Table 2).
Misperception of the Trunk Position
We found a misperception of the trunk position in 100% of PS
patients (n = 12/12), with an average underestimation of the
trunk bending angle of 11.7◦ ± 4.3. Moreover, all PS+ patients
referred a subjective feeling of bending on the opposite side
compared to their PS bending side when passively positioned on
the vertical line (0◦) with their eyes closed (e.g., patients with
right-sided PS referred to bend on the left side and vice versa).
The degree of misperception of the trunk position showed
a trend toward a correlation with the visual-spatial CI
score (p: 0.089).
DISCUSSION
This pilot study supports the hypothesis of a specific
neuropsychological profile of PD patients with PS. In fact,
we found a worse performance in the visual-spatial, attentional,
and language domains in PD patients with PS compared with
a matched group of PD patients without posture alterations.
Moreover, we found a misperception of the trunk position in all
PS patients, which showed a possible correlation with the score
of visual-spatial abilities.
The role of the Central Nervous System in the
pathophysiology of PD-associated PS is sustained by a vast
body of evidence (1); however, the exact pathophysiological
mechanism underlying PS is still a matter of debate. Altered
perception of verticality in PS patients has been reported by
different studies (4, 27), and this defect is supposed to be
associated with the impaired integration of visual, vestibular
and somatosensory information. A recent study on 54 patients
with PS demonstrated that vertical misperception is not only
a feature of PS patients but also a relevant risk factor for PS
development (4). To date, only one study investigated by means
of a comprehensive neuropsychological battery the cognitive
profile of patients with PS, concluding that PS may be associated
with altered performance in attention and posterior cortical
functions (3).
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TABLE 2 | Neuropsychological scores obtained by the overall sample and comparison between PS+ and PS– group.
Overall sample PS+ group PS– group p-value
Mean ± standard
deviation
(range)
Mean ± standard
deviation
(range)
Mean ± standard
deviation
(range)
MoCA 22.6 ± 4.4
(13–30)
21.7 ± 4.8
(13–30)
23.5 ± 3.9
(15–27)
0.223
RCPMT 26.3 ± 7
(12–36)
25.7 ± 6.6
(16–35)
26.9 ± 7.6
(12–36)
0.664
BWRT 3.9 ± 0.9
(3–6)
3.6 ± 0.7
(3–5)
4.2 ± 1.1
(3–6)
0.102
DST 4.9 ± 1.3
(3–8)
4.8 ± 0.9
(4–6)
5.1 ± 1.6
(3–8)
0.721
CBT 4.3 ± 0.7
(3–6)
3.9 ± 0.5
(3–5)
4.7 ± 0.6
(4–6)
0.007
RAVLT–Immediate
recall
35.1 ± 11.7
(15–59)
31.7 ± 12.6
(15–55)
38.6 ± 10.1
(24–59)
0.118
RAVLT–Delayed recall 6.9 ± 3.7
(0–13)
6.9 ± 3.7
(0–13)
7 ± 3.8
(2–13)
0.977
ROCFT–Copy 31 ± 5.6
(17–36)
27.9 ± 6.1
(17–36)
34.3 ± 2
(30–36)
0.004
ROCFT–Delayed recall 13.9 ± 6.4
(3–30)
11.9 ± 4.6
(4–18)
16.2 ± 7.5
(3–30)
0.056
DCT 42.6 ± 11.3
(15–60)
36.2 ± 10.6
(15–51)
49 ± 8.1
(36–60)
0.003
TMT A 63.6 ± 33.5
(22–143)
77.2 ± 35.2
(44–143)
49.9 ± 26.6
(22–114)
0.040
TMT B 188.2 ± 144.7
(42–532)
250.2 ± 158.6
(91–532)
126.2 ± 101.3
(42–400)
0.018
TMT B-A 130.1 ± 127.9
(20–400)
183.8 ± 145
(28–400)
76.3 ± 82.9
(20–319)
0.057
FAB 14.3 ± 2.9
(9–18)
13.2 ± 2.7
(9–17)
15.4 ± 2.7
(9–18)
0.050
MCST–Categories 4.4 ± 1.6
(2–6)
4.1 ± 1.7
(2–6)
4.7 ± 1.6
(2–6)
0.355
MCST–Errors 6.7 ± 5.3
(0–22)
6.2 ± 3.9
(0–11)
7.3 ± 6.6
(0–22)
0.766
MCST–Perseverative
errors
3.6 ± 3.7
(0–11)
4.8 ± 4
(0–11)
2.4 ± 3.1
(0–10)
0.096
CAT 12 ± 1.8
(7–14)
11 ± 1.8
(7–13)
13.1 ± 1
(11–14)
0.003
BJLOT 21.7 ± 4.5
(13–29)
19.3 ± 4.4
(13–28)
23.4 ± 3.9
(17–29)
0.039
PVF 32.1 ± 14.6
(11–64)
27.2 ± 9.5
(11–40)
37.1 ± 17.4
(17–64)
0.204
SVF 20.8 ± 6.9
(12–36)
18.3 ± 6.5
(12–32)
23.4 ± 6.5
(12–36)
0.057
MoCA, Montreal Cognitive Assessment; RCPMT, Raven Colored Progressive Matrices Test; BWRT, Italian Bi-syllabic Words Repetition Test; DST, Digit Span Test; CBT, Corsi’s Block
Tapping Test; RAVLT, Rey Auditory Verbal Learning test; ROCFT, Rey-Osterrieth Complex Figure Test; DCT, Digit Cancellation Test; TMT A, Trail Making Test A; TMT B, Trail Making Test
B; TMT B-A, Trail Making Test B-A; FAB, Frontal Assessment Battery; MCST, Modified Card Sorting Test; CAT, Constructional Apraxia Test; BJLOT, Benton Judgment of Line Orientation
Test; PVF, Phonological Verbal Fluency; SVF, Semantic Verbal Fluency. Bold values mean statistically significant difference.
Our study confirms the presence of specific
neuropsychological alterations in PS, endorsing a possible
role for visual-spatial and attentional impairment. In particular,
our data indicate a correlation between PS and specific cortical
cognitive deficits, which can be strictly related to the perception
of the trunk position in the space. Indeed, we also observed
that all PS patients had a significant misperception of their
trunk position, with a possible correlation between the severity
of misperception and the severity of visual-spatial deficits.
In addition, we found a worse performance in the language
domain, particularly for the access to the semantic lexicon, an
ability related to the infero-posterior temporal lobe function that
involves the semantic representation of nouns or objects mostly
constituted of perceptual/sensory content (28). Alterations in
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language performance in PD proved to be similar to those
observed in Lewy Body dementia, typically characterized
by visual-spatial deficits, and different to those observed in
Alzheimer disease. This data, while requesting confirmation in
larger studies, may suggest a further link between visuoperceptual
dysfunctions and PS.
While some authors hypothesized the contribution of
peripheral proprioceptive or vestibular apparatus alterations in
the pathophysiology of PS, a recent study showed that most PS
patients do not suffer from peripheral deficits (4), suggesting
the involvement of higher subcortical and cortical networks.
Moreover, PD patients with PS showed a higher tendency to
have a veering gait compared to PD patients without PS (2),
and this phenomenon has been correlated with visual-perceptual
impairment (29). Accordingly, our results showed the presence
of altered performance in neuropsychological tests related to
visual-perceptual abilities. These findings represent a clue for
the role of high cognitive functions in the pathophysiology of
PS, highlighting the importance of early management of PS
patients with both physical and neuropsychological rehabilitative
programs (2).
The strength of our findings should be tempered by the small
sample size, and the absence of a follow-up with the possibility
to establish whether the cognitive deficits preceded or followed
the onset of PS. Moreover, PS+ patients showed a higher MDS-
UPDRS-III score than PS–. While this finding could be partly
explained by the higher score obtained in the posture item by
patients with PS, a more aggressive disease phenotype cannot be
excluded in spite of the strict matching criteria applied. Finally,
we did not investigate a possible vestibular dysfunction, which
has been previously associated with impairment in visual-spatial
abilities (30).
In conclusion, considering these limitations, our study reveals
an association between PS and specific cognitive alterations,
suggesting a potential contribution of cortical and subcortical
dysfunctions in the pathophysiology of PS. A longitudinal, multi-
center study is necessary to confirm these findings and to clarify
the role of specific cognitive alterations as a risk factor for PS.
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CONTRIBUTION TO THE FIELD
STATEMENT
Pisa syndrome (PS) is a disabling posture alteration affecting
almost 10% of patients with Parkinson’s disease (PD). However,
the pathophysiology of PS still needs to be elucidated, and
the absence of known pathophysiology reflects on the absence
of specific therapies. While proving the role of the central
nervous system, some information provided by the literature
seems to suggest a role of cognitive functions in determining
PS. Nonetheless, to our knowledge, only one study investigated
so far the cognitive profile of PS patients. The results of our
study endorse the hypothesis of specific cognitive dysfunction
associated with PS. Pointing out the role of visual-spatial
abilities and attention deficits in PS patients, our findings
provide an important piece of information in the debate on PS
pathophysiology, at the same time highlighting the importance
of early management of PS patients with both physical and
neuropsychological rehabilitative programs.
REFERENCES
1. Doherty KM, van de Warrenburg BP, Peralta MC, Silveira-Moriyama L,
Azulay JP, Gershanik OS, et al. Postural deformities in Parkinson’s disease.
Lancet Neurol. (2011) 10:538–49. doi: 10.1016/S1474-4422(11)70067-9
2. Tinazzi M, Geroin C, Gandolfi M, Smania N, Tamburin S, Morgante
F, et al. Pisa syndrome in Parkinson’s disease: an integrated approach
from pathophysiology to management. Mov Disord. (2016) 31:1785–95.
doi: 10.1002/mds.26829
3. Vitale C, Falco F, Trojano L, Erro R, Moccia M, Allocca R, et al.
Neuropsychological correlates of Pisa syndrome in patients with Parkinson’s
disease. Acta Neurol Scand. (2016) 134:101–7. doi: 10.1111/ane.12514
4. Huh YE, Kim K, Chung WH, Youn J, Kim S, Cho JW. Pisa syndrome in
Parkinson’s disease: pathogenic roles of verticality perception deficits. Sci Rep.
(2018) 8:1804. doi: 10.1038/s41598-018-20129-2
5. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al.
MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. (2015)
30:1591–601. doi: 10.1002/mds.26424
6. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-
Martin P, et al. Movement disorder society UPDRS revision task force.
Movement Disorder Society-sponsored revision of the Unified Parkinson’s
Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric
testing results. Mov Disord. (2008) 23:2129–70. doi: 10.1002/mds.
22340
Frontiers in Neurology | www.frontiersin.org 6 May 2019 | Volume 10 | Article 577
Artusi et al. Neuropsychological Profile of Pisa Syndrome
7. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V,
Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening
tool for mild cognitive impairment. J Am Geriatr Soc. (2005) 53:695–9.
doi: 10.1111/j.1532-5415.2005.53221.x
8. Benton AL, Varney NR, Hamsher KD. Visuospatial judgement: a clinical test.
Arch Neurol. (1978) 35:364–7. doi: 10.1001/archneur.1978.00500300038006
9. Spinnler H, Tognoni G. Standardizzazione e Taratura Italiana di Test
Neuropsicologici. Ital J Neurol Sci. (1987) 6:1–120.
10. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Rey-Osterrieth complex
figure: normative values in an Italian population sample. Neurol Sci. (2002)
2:443–7. doi: 10.1007/s100720200003
11. Orsini A, Grossi D, Capitani E, Laiacona M, Papagno C, Vallar G. Verbal and
spatial immediate memory span: normative data from 1355 adults and 1112
children. Ital. J. Neurol Sci. (1987) 8:539–48. doi: 10.1007/BF02333660
12. Carlesimo GA, Caltagirone C, Gainotti G, MDB Group. The mental
deterioration battery: normative data, diagnostic reliability and qualitative
analyses of cognitive impairment. Eur Neurol. (1996) 36:378–84.
doi: 10.1159/000117297
13. Measso G, Zappalà G, Cavarzeran F, Crook TH, Romani L, Pirozzolo
FJ, et al. Raven’s coloured progressive matrices: a normative study of
a random sample of healthy adults. Acta Neurol Scand. (1993) 88:70–4.
doi: 10.1111/j.1600-0404.1993.tb04190.x
14. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M,
Capitani E. Trail making test: normative values from 287 normal adult
controls. Ital J Neurol Sci. (1996) 17:305–9. doi: 10.1007/BF01997792
15. Appollonio I, Leone M, Isella V, Pianmarta F, Consoli T, Villa ML, et al. The
Frontal Assessment Battery (FAB): normative values in an Italian population
sample. Neurol Sci. (2005) 26:108–16. doi: 10.1007/s10072-005-0443-4
16. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Modified card
sorting test: normative data. J Clin Exp Neuropsychol. (2004) 26:246–50.
doi: 10.1076/jcen.26.2.246.28087
17. Zappalà G, Measso G, Cavarzeran F, Grigoletto F, Lebowitz B, Pirozzolo
F, et al. Aging and memory: corrections for age, sex and education for
three widely used memory tests. Ital J Neurol Sci. (1995) 16:177–84.
doi: 10.1007/BF02282985
18. Aybek S, Gronchi-Perrin A, Berney A, Chiuvé SC, Villemure JG, Burkhard PR,
et al. Long-term cognitive profile and incidence of dementia after STN-DBS in
Parkinson’s disease.Mov Disord. (2007) 22:974–81. doi: 10.1002/mds.21478
19. Merola A, Rizzi L, Artusi CA, Zibetti M, Rizzone MG, Romagnolo A,
et al. Subthalamic deep brain stimulation: clinical and neuropsychological
outcomes in mild cognitive impaired parkinsonian patients. J Neurol. (2014)
261:1745–51. doi: 10.1007/s00415-014-7414-8
20. Capitani E, Laiacona M. Composite neuropsychological batteries and
demographic correction: standardization based on equivalent scores, with a
review of published data. The Italian Group for the Neuropsychological
Study of Ageing. J Clin Exp Neuropsychol. (1997) 19: 795–809.
doi: 10.1080/01688639708403761
21. Artusi CA, Bortolani S, Merola A, Zibetti M, Busso M, De Mercanti
S, et al. Botulinum toxin for Pisa syndrome: an MRI-, ultrasound- and
electromyography-guided pilot study. Parkinsonism Relat Disord. (2018).
doi: 10.1016/j.parkreldis.2018.11.003. [Epub ahead of print].
22. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of
image analysis. Nat Methods. (2012) 9:671–5. doi: 10.1038/nmeth.2089
23. Mikami K, Shiraishi M, Kawasaki T, Kamo T. Forward flexion of
trunk in Parkinson’s disease patients is affected by subjective vertical
position. PLoS ONE. (2017) 12:e0181210. doi: 10.1371/journal.pone.
0181210
24. Beck AT. Beck Depression Inventory. San Antonio, TX: Psychological
Corporation (1987).
25. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity
of the Apathy evaluation scale. Psychiatry Res. (1991) 38:143–62.
doi: 10.1016/0165-1781(91)90040-V
26. Spielberger CD. State-Trait Anxiety Inventory. Palo Alto, CA: Consulting
Psychologists Press (1983).
27. Scocco DH, Wagner JN, Racosta J, Chade A, Gershanik OS. Subjective visual
vertical in Pisa syndrome. Parkinsonism Relat Disord. (2014) 20:878–83.
doi: 10.1016/j.parkreldis.2014.04.030
28. Patterson K, Nestor PJ, Rogers TT. Where do you know what you know? The
representation of semantic knowledge in the human brain. Nat Rev Neurosci.
(2007) 8:976–87. doi: 10.1038/nrn2277
29. Ren X, Salazar R, Neargarder S, Roy S, Ellis TD, Saltzman E, et al.
Veering in hemi-Parkinson’s disease: primacy of visual over motor
contributions. Vision Res. (2015) 115:119–27. doi: 10.1016/j.visres.2015.
08.011
30. Bigelow RT, Semenov YR, Trevino C, Ferrucci L, Resnick SM, Simonsick EM,
et al. Association between visuospatial ability and vestibular function in the
baltimore longitudinal study of aging. J Am Geriatr Soc. (2015) 63:1837–44.
doi: 10.1111/jgs.13609
Disclosure: CA has received travel grants from Zambon and Abbvie. AR has
received grant support and speaker honoraria from AbbVie, speaker honoraria
from Chiesi Farmaceutici and travel grants from Medtronic, Lusofarmaco, and
UCB Pharma. MZ has received speaker’s honoraria from Medtronic, Lundbeck,
UCB Pharma, and AbbVie. LL has received honoraria for lecturing and travel
grants from, UCB Pharma, AbbVie, DOC, Zambon, and Bial. EM and ST reports
no disclosures.
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Artusi, Montanaro, Tuttobene, Romagnolo, Zibetti and Lopiano.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Neurology | www.frontiersin.org 7 May 2019 | Volume 10 | Article 577
